Natiijooyin degdeg ah 15-30 daqiiqo Qalabka antigen-ka degdega ah AMRDT120

Tijaabo degdeg ah oo lagu ogaanayo tayada dhexdhexaadinta

unugyada difaaca jirka ee SARS-CoV-2 ama tallaalada ku jira dhiiga oo dhan, serum, ama balasmaha.

Xirmada cayiman: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.

Dareenka Qaraabada: 96.97% (95%CI:83.35%～99.99%)
Gaar ahaan Qaraabada: 100.00% (95%CI:97.29%～100.00%)
Saxnimada: 99.50% (95%CI:96.94%～99.99%)

Kiishash biil ah, oo ay ku jiraan cajalado tijaabo ah iyo kuwa qallajiya *20
Assay baffer * 20 fijaan;
Dhibcaha la tuuri karo*20;
Lancet *20
Lodine suuf*20
Tilmaamaha isticmaalka*1

Natiijooyin degdeg ah gudaha 15-30 daqiiqo Qalabka antigen-ka degdega ah AMRDT120 ISTICMAALO
Tijaabada degdega ah ee ka hortagga jirka ee SARS-CoV-2 (COVID-19 Ab) waa immunoassay chromatographic degdeg ah oo loogu talagalay ogaanshaha tayada leh ee ka takhalusidda unugyada ka hortagga SARS-CoV-2 ee dhiigga oo dhan, serum, ama balasmaha.

Natiijooyin degdeg ah 15-30 daqiiqo Qalabka antigen-ka degdega ah ee AMRDT120 PRINCIPLE
Baaritaanka degdega ah ee ka hortagga jirka ee SARS-CoV-2 (COVID-19 Ab) waxaa loogu talagalay ogaanshaha unugyada difaaca jirka ee SARS-CoV-2 ama tallaaladiisa.Qalabka dusha sare ee unugyada angiotensin beddelka enzyme-2 (ACE2) waxay ku dahaadhan yihiin gobolka khadka tijaabada iyo recombinant recombinant reseptor-binding domain (RBD) oo ay la socdaan qaybaha tilmaamaya.

Inta lagu jiro tijaabada, haddii ay jiraan SARS-CoV-2 unugyada difaaca jirka ee muunada, waxay la falcelin doontaa borotiinka RBD-isku-xidhaha oo kama falcelinayso borotiinka hore loo dahaadhay ee ACE2.Isku darka ayaa markaa kor ugu hayaamaya xuubka chromatographically iyadoo la raacayo ficilka capillary mana qabsan doono antigen-ka hore loo dahaadhay.Tijaabada degdega ah ee ka hortagga jidhka ee SARS-CoV-2 (COVID-19 Ab) waxay ka kooban tahay qaybo ka samaysan borotiin RBD.borotiinka ACE2 waxa lagu dahaadhay gobolka khadka tijaabada ah.